{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:46:38Z","timestamp":1793810798326,"version":"4.6.1"},"reference-count":109,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMedLife"],"DOI":"10.25122\/jml-2024-0274","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T11:11:21Z","timestamp":1730200281000},"page":"746-754","source":"Crossref","is-referenced-by-count":5,"title":["Protecting the elderly from influenza in the context of immune system senescence. Elderly aged 65 and over are vulnerable to influenza and its associated complications."],"prefix":"10.25122","volume":"17","author":[{"given":"Gabriela-Cristina","family":"Chelu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"National Institute of Gerontology and Geriatrics Ana Aslan, Bucharest, Romania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel-Ioan","family":"Prada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"National Institute of Gerontology and Geriatrics Ana Aslan, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Academy of Romanian Scientists, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovidiu-Lucian","family":"B\u0103jenaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"National Institute of Gerontology and Geriatrics Ana Aslan, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina-Marilena","family":"Matei-Linc\u0103","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u0103t\u0103lina-Raluca","family":"Nu\u0163\u0103","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"National Institute of Gerontology and Geriatrics Ana Aslan, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00eenziana-Georgeta","family":"Moscu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"National Institute of Gerontology and Geriatrics Ana Aslan, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10755","published-online":{"date-parts":[[2024,7]]},"reference":[{"issue":"10127","key":"ref1","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Lancet","volume":"391","author":"Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S","year":"2018","unstructured":"1. Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, Lancet, 2018;391(10127):1285-1300"},{"issue":"16","key":"ref2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2807\/1560-7917.ES.2018.23.16.17-00454","article-title":"Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013","volume":"23","author":"Cassini A, Colzani E, Pini A, Mangen MJ, Plass D, McDonald SA","year":"2018","unstructured":"2. Cassini A, Colzani E, Pini A, Mangen MJ, Plass D, McDonald SA, Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013, Euro Surveill, 2018;23(16):17-00454","journal-title":"Euro Surveill"},{"issue":"1","key":"ref3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrmicro.2017.118","article-title":"The evolution of seasonal influenza viruses","volume":"16","author":"Petrova VN, Russell CA","year":"2018","unstructured":"3. Petrova VN, Russell CA, The evolution of seasonal influenza viruses, Nat Rev Microbiol, 2018;16(1):47-60","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"ref4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1055\/s-0043-105850","article-title":"Der Mensch und Influenza\u2013ein \u00dcberblick [Human and Influenza-an Overview]","volume":"72","author":"Frenzen F","year":"2018","unstructured":"4. Frenzen F, Der Mensch und Influenza\u2013ein \u00dcberblick [Human and Influenza-an Overview], Pneumologie, 2018;72(3):207-221German","journal-title":"Pneumologie"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1038\/ncomms2922","article-title":"Aerosol transmission is an important mode of influenza A virus spread","volume":"4","author":"Cowling BJ, Ip DK, Fang VJ, Suntarattiwong P, Olsen SJ, Levy J","year":"2013","unstructured":"5. Cowling BJ, Ip DK, Fang VJ, Suntarattiwong P, Olsen SJ, Levy J, Aerosol transmission is an important mode of influenza A virus spread, Nat Commun, 2013;41935","journal-title":"Nat Commun"},{"issue":"10095","key":"ref6","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0140-6736(17)30129-0","article-title":"Influenza","volume":"390","author":"Paules C, Subbarao K","year":"2017","unstructured":"6. Paules C, Subbarao K, Influenza, Lancet, 2017;390(10095):697-708","journal-title":"Lancet"},{"key":"ref7","first-page":"19","article-title":"Viral shedding, clinical history and transmission of influenza","volume":"19","author":"Cowling BJ, Chan KH, Peiris JS, Riley S, Leung GM","year":"2013","unstructured":"7. Cowling BJ, Chan KH, Peiris JS, Riley S, Leung GM, Viral shedding, clinical history and transmission of influenza, Hong Kong Med J, 2013;19(Suppl 4):19-23","journal-title":"Hong Kong Med J"},{"key":"ref8","article-title":"Influenza Laboratory Surveillance Information. Microsoft Power BI","author":"World Health Organization","year":"2024","unstructured":"8. World Health Organization, Influenza Laboratory Surveillance Information. Microsoft Power BI, 2024;Available from: Link"},{"issue":"6","key":"ref9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S2213-2600(14)70034-7","article-title":"Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study","volume":"2","author":"Hayward AC, Fragaszy EB, Bermingham A, Wang L, Copas A, Edmunds WJ","year":"2014","unstructured":"9. Hayward AC, Fragaszy EB, Bermingham A, Wang L, Copas A, Edmunds WJ, Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study, Lancet Respir Med, 2014;2(6):445-54","journal-title":"Lancet Respir Med"},{"issue":"10","key":"ref10","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1001\/archinte.161.10.1351","article-title":"Clinical signs and symptoms predicting influenza infection","volume":"161","author":"Hak E, Moons KG, Verheij TJ, Hoes AW","year":"2001","unstructured":"10. Hak E, Moons KG, Verheij TJ, Hoes AW, Clinical signs and symptoms predicting influenza infection, Arch Intern Med, 2001;161(10):1351-2","journal-title":"Arch Intern Med"},{"issue":"1","key":"ref11","first-page":"2","article-title":"A Narrative Review of Influenza: A Seasonal and Pandemic Disease","volume":"42","author":"Moghadami M","year":"2017","unstructured":"11. Moghadami M, A Narrative Review of Influenza: A Seasonal and Pandemic Disease, Iran J Med Sci, 2017;42(1):2-13","journal-title":"Iran J Med Sci"},{"issue":"21","key":"ref12","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1001\/archinte.160.21.3243","article-title":"Clinical signs and symptoms predicting influenza infection","volume":"160","author":"Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J","year":"2000","unstructured":"12. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J, Clinical signs and symptoms predicting influenza infection, Arch Intern Med, 2000;160(21):3243-7","journal-title":"Arch Intern Med"},{"issue":"9","key":"ref13","doi-asserted-by":"publisher","first-page":"e0136186","DOI":"10.1371\/journal.pone.0136186","article-title":"Clinical Characteristics Are Similar across Type A and B Influenza Virus Infections","volume":"10","author":"Mosnier A, Caini S, Daviaud I, Nauleau E, Bui TT, Debost E","year":"2015","unstructured":"13. Mosnier A, Caini S, Daviaud I, Nauleau E, Bui TT, Debost E, Clinical Characteristics Are Similar across Type A and B Influenza Virus Infections, PLoS One, 2015;10(9):e0136186","journal-title":"PLoS One"},{"issue":"10","key":"ref14","doi-asserted-by":"publisher","first-page":"e714","DOI":"10.1016\/j.ijid.2012.05.1025","article-title":"A review on the clinical spectrum and natural history of human influenza","volume":"16","author":"Punpanich W, Chotpitayasunondh T","year":"2012","unstructured":"14. Punpanich W, Chotpitayasunondh T, A review on the clinical spectrum and natural history of human influenza, Int J Infect Dis, 2012;16(10):e714-23","journal-title":"Int J Infect Dis"},{"issue":"9","key":"ref15","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1046\/j.1532-5415.2002.50404.x","article-title":"Clinical features of influenza A virus infection in older hospitalized persons","volume":"50","author":"Walsh EE, Cox C, Falsey AR","year":"2002","unstructured":"15. Walsh EE, Cox C, Falsey AR, Clinical features of influenza A virus infection in older hospitalized persons, J Am Geriatr Soc, 2002;50(9):1498-503","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"ref16","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1001\/jama.292.11.1333","article-title":"Influenza-associated hospitalizations in the United States","volume":"292","author":"Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K","year":"2004","unstructured":"16. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K, Influenza-associated hospitalizations in the United States, JAMA, 2004;292(11):1333-40","journal-title":"JAMA"},{"issue":"20","key":"ref17","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1056\/NEJMoa0906695","article-title":"Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009","volume":"361","author":"Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J","year":"2009","unstructured":"17. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009, N Engl J Med, 2009;361(20):1935-44","journal-title":"N Engl J Med"},{"issue":"1","key":"ref18","first-page":"E13","article-title":"Influenza vaccination in high-risk groups: a revision of existing guidelines and rationale for an evidence-based preventive strategy","volume":"57","author":"Costantino C, Vitale F","year":"2016","unstructured":"18. Costantino C, Vitale F, Influenza vaccination in high-risk groups: a revision of existing guidelines and rationale for an evidence-based preventive strategy, J Prev Med Hyg, 2016;57(1):E13-8","journal-title":"J Prev Med Hyg"},{"issue":"5","key":"ref19","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1183\/09031936.00186214","article-title":"Influenza virus-induced lung injury: pathogenesis and implications for treatment","volume":"45","author":"Herold S, Becker C, Ridge KM, Budinger GR","year":"2015","unstructured":"19. Herold S, Becker C, Ridge KM, Budinger GR, Influenza virus-induced lung injury: pathogenesis and implications for treatment, Eur Respir J, 2015;45(5):1463-78","journal-title":"Eur Respir J"},{"issue":"4","key":"ref20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrmicro3231","article-title":"The co-pathogenesis of influenza viruses with bacteria in the lung","volume":"12","author":"McCullers JA","year":"2014","unstructured":"20. McCullers JA, The co-pathogenesis of influenza viruses with bacteria in the lung, Nat Rev Microbiol, 2014;12(4):252-62","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"ref21","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13054-019-2539-x","article-title":"Influenza virus-related critical illness: pathophysiology and epidemiology","volume":"23","author":"Kalil AC, Thomas PG","year":"2019","unstructured":"21. Kalil AC, Thomas PG, Influenza virus-related critical illness: pathophysiology and epidemiology, Crit Care, 2019;23(1):258","journal-title":"Crit Care"},{"issue":"2","key":"ref22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.4049\/jimmunol.1801010","article-title":"Influenza Pathogenesis: The Effect of Host Factors on Severity of Disease","volume":"202","author":"Gounder AP, Boon ACM","year":"2019","unstructured":"22. Gounder AP, Boon ACM, Influenza Pathogenesis: The Effect of Host Factors on Severity of Disease, J Immunol, 2019;202(2):341-350","journal-title":"J Immunol"},{"issue":"3","key":"ref23","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/cvr\/cvaa117","article-title":"Human influenza A virus causes myocardial and cardiac-specific conduction system infections associated with early inflammation and premature death","volume":"117","author":"Filgueiras-Rama D, Vasilijevic J, Jalife J, Noujaim SF, Alfonso JM, Nicolas-Avila JA","year":"2021","unstructured":"23. Filgueiras-Rama D, Vasilijevic J, Jalife J, Noujaim SF, Alfonso JM, Nicolas-Avila JA, Human influenza A virus causes myocardial and cardiac-specific conduction system infections associated with early inflammation and premature death, Cardiovasc Res, 2021;117(3):876-889","journal-title":"Cardiovasc Res"},{"issue":"4","key":"ref24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1056\/NEJMoa1702090","article-title":"Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection","volume":"378","author":"Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T","year":"2018","unstructured":"24. Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection, N Engl J Med, 2018;378(4):345-353","journal-title":"N Engl J Med"},{"issue":"1","key":"ref25","first-page":"4","article-title":"Influenza and cardiovascular disease: is there a causal relationship?","volume":"31","author":"Madjid M, Aboshady I, Awan I, Litovsky S, Casscells SW","year":"2004","unstructured":"25. Madjid M, Aboshady I, Awan I, Litovsky S, Casscells SW, Influenza and cardiovascular disease: is there a causal relationship?, Tex Heart Inst J, 2004;31(1):4-13","journal-title":"Tex Heart Inst J"},{"issue":"1","key":"ref26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1517\/14712598.5.1.91","article-title":"Influenza and atherosclerosis: vaccination for cardiovascular disease prevention","volume":"5","author":"Madjid M, Awan I, Ali M, Frazier L, Casscells W","year":"2005","unstructured":"26. Madjid M, Awan I, Ali M, Frazier L, Casscells W, Influenza and atherosclerosis: vaccination for cardiovascular disease prevention, Expert Opin Biol Ther, 2005;5(1):91-6","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"ref27","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1001\/jamacardio.2016.0433","article-title":"Seasonal Influenza Infections and Cardiovascular Disease Mortality","volume":"1","author":"Nguyen JL, Yang W, Ito K, Matte TD, Shaman J, Kinney PL","year":"2016","unstructured":"27. Nguyen JL, Yang W, Ito K, Matte TD, Shaman J, Kinney PL, Seasonal Influenza Infections and Cardiovascular Disease Mortality, JAMA Cardiol, 2016;1(3):274-81","journal-title":"JAMA Cardiol"},{"issue":"5","key":"ref28","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jiph.2018.05.003","article-title":"Myocarditis associated with influenza infection in five children","volume":"11","author":"Aykac K, Ozsurekci Y, Kahyaoglu P, Basaranoglu ST, Ertugrul I, Alp A","year":"2018","unstructured":"28. Aykac K, Ozsurekci Y, Kahyaoglu P, Basaranoglu ST, Ertugrul I, Alp A, Myocarditis associated with influenza infection in five children, J Infect Public Health, 2018;11(5):698-701","journal-title":"J Infect Public Health"},{"issue":"1","key":"ref29","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1186\/s12879-019-4636-5","article-title":"Characteristics and outcome of influenza-associated encephalopathy\/encephalitis among children in a tertiary pediatric hospital in Italy, 2017-2019","volume":"19","author":"Mastrolia MV, Rubino C, Resti M, Trapani S, Galli L","year":"2019","unstructured":"29. Mastrolia MV, Rubino C, Resti M, Trapani S, Galli L, Characteristics and outcome of influenza-associated encephalopathy\/encephalitis among children in a tertiary pediatric hospital in Italy, 2017-2019, BMC Infect Dis, 2019;19(1):1012","journal-title":"BMC Infect Dis"},{"issue":"6","key":"ref30","doi-asserted-by":"publisher","first-page":"e005076","DOI":"10.1099\/jmmcr.0.005076","article-title":"Acute influenza virus-associated encephalitis and encephalopathy in adults: a challenging diagnosis","volume":"3","author":"Meijer WJ, Linn FH, Wensing AM, Leavis HL, van Riel D, GeurtsvanKessel CH","year":"2016","unstructured":"30. Meijer WJ, Linn FH, Wensing AM, Leavis HL, van Riel D, GeurtsvanKessel CH, Acute influenza virus-associated encephalitis and encephalopathy in adults: a challenging diagnosis, JMM Case Rep, 2016;3(6):e005076","journal-title":"JMM Case Rep"},{"issue":"7","key":"ref31","doi-asserted-by":"publisher","first-page":"e228201","DOI":"10.1136\/bcr-2018-228201","article-title":"Fatal influenza myocarditis with incessant ventricular tachycardia","volume":"12","author":"Saraiya N, Singh S, Corpuz M","year":"2019","unstructured":"31. Saraiya N, Singh S, Corpuz M, Fatal influenza myocarditis with incessant ventricular tachycardia, BMJ Case Rep, 2019;12(7):e228201","journal-title":"BMJ Case Rep"},{"issue":"3","key":"ref32","doi-asserted-by":"publisher","first-page":"e1003550","DOI":"10.1371\/journal.pmed.1003550","article-title":"Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis","volume":"18","author":"Lafond KE, Porter RM, Whaley MJ, Suizan Z, Ran Z, Aleem MA","year":"2021","unstructured":"32. Lafond KE, Porter RM, Whaley MJ, Suizan Z, Ran Z, Aleem MA, Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis, PLoS Med, 2021;18(3):e1003550","journal-title":"PLoS Med"},{"key":"ref33","article-title":"Estimated Flu-Related Illnesses, Medical visits, Hospitalizations, and Deaths in the United States\u20142019-2020 Flu Season","author":"CDC","unstructured":"33. CDC, Estimated Flu-Related Illnesses, Medical visits, Hospitalizations, and Deaths in the United States\u20142019-2020 Flu Season, Available from: https:\/\/www.cdc.gov\/flu\/about\/burden\/2019-2020.html"},{"issue":"3","key":"ref34","doi-asserted-by":"publisher","first-page":"e1001977","DOI":"10.1371\/journal.pmed.1001977","article-title":"Global role and burden of influenza in pediatric respiratory hospitalizations, 1982\u20132012: a systematic analysis","volume":"13","author":"Lafond KE, Nair H, Rasooly MH, Valente F, Booy R, Rahman M","year":"2016","unstructured":"34. Lafond KE, Nair H, Rasooly MH, Valente F, Booy R, Rahman M, Global role and burden of influenza in pediatric respiratory hospitalizations, 1982\u20132012: a systematic analysis, PLoS Med, 2016;13(3):e1001977","journal-title":"PLoS Med"},{"issue":"1","key":"ref35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S2213-2600(18)30496-X","article-title":"2017 an analysis for the Global Burden of Disease Study 2017","volume":"7","author":"GBD 2017 Influenza Collaborators, Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections","year":"2019","unstructured":"35. GBD 2017 Influenza Collaborators, Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017 an analysis for the Global Burden of Disease Study 2017, Lancet Respir Med, 2019;7(1):69-89","journal-title":"Lancet Respir Med"},{"key":"ref36","article-title":"Surveillance Data Analysis","author":"National Institute of Public Health, Romania","unstructured":"36. National Institute of Public Health, Romania, Surveillance Data Analysis, Available from: https:\/\/insp.gov.ro\/centrul-national-de-supraveghere-si-control-al-bolilor-transmisibile-cnscbt\/analiza-date-supraveghere\/"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1164\/ajrccm\/136.3.550","article-title":"Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981","volume":"136","author":"Glezen WP, Decker M, Perrotta DM","year":"1987","unstructured":"37. Glezen WP, Decker M, Perrotta DM, Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981, Am Rev Respir Dis, 1987;136550-5","journal-title":"Am Rev Respir Dis"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1750-2659.2008.00035.x","article-title":"Role of influenza and other respiratory viruses in admissions of adults to Canadian hospitals","volume":"2","author":"Schanzer DL, Langley JM, Tam TWS","year":"2008","unstructured":"38. Schanzer DL, Langley JM, Tam TWS, Role of influenza and other respiratory viruses in admissions of adults to Canadian hospitals, Influenza Other Respir Viruses, 2008;21-8","journal-title":"Influenza Other Respir Viruses"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1164\/ajrccm.164.9.2105011","article-title":"Respiratory viruses, symptoms, and inflammatory markers inacute exacerbations and stable chronic obstructive pulmonary disease","volume":"164","author":"Seemunga lT, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S","year":"2001","unstructured":"39. Seemunga lT, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Respiratory viruses, symptoms, and inflammatory markers inacute exacerbations and stable chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 2001;1641618-23","journal-title":"Am J Respir Crit Care Med"},{"key":"ref40","article-title":"Chronic obstructive pulmonary disease (COPD)","author":"WHO","unstructured":"40. WHO, Chronic obstructive pulmonary disease (COPD), Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chronic-obstruc-tive-pulmonary-disease-(copd)."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2147\/copd.2007.2.1.55","article-title":"Influenza infection and COPD","volume":"2","author":"Mallia P, Johnston SL","year":"2007","unstructured":"41. Mallia P, Johnston SL, Influenza infection and COPD, Int J COPD, 2007;255-64","journal-title":"Int J COPD"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.rmed.2008.06.006","article-title":"Respiratory viral infection inexacerbations of COPD","volume":"102","author":"McManus TE, Marley A-M, Baxter N, Christie SN, O\u2019Neill HJ, Elborn JS","year":"2008","unstructured":"42. McManus TE, Marley A-M, Baxter N, Christie SN, O\u2019Neill HJ, Elborn JS, Respiratory viral infection inexacerbations of COPD, Respir Med, 2008;1021575-80","journal-title":"Respir Med"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/j.1440-1843.2010.01722","article-title":"Prevalence of viral infection detected by PCR and RT-PCR inpatients with acute exacerbation of COPD: asystematic review","volume":"15","author":"Mohan A, Chandra S, Agarwa D, Guleria R, Broor S, Gaur B","year":"2010","unstructured":"43. Mohan A, Chandra S, Agarwa D, Guleria R, Broor S, Gaur B, Prevalence of viral infection detected by PCR and RT-PCR inpatients with acute exacerbation of COPD: asystematic review, Respirology, 2010;15536-42","journal-title":"Respirology"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.vaccine.2006.10.015","article-title":"Impact of influenza vaccination on major cause-specific mortality","volume":"25","author":"Wang C-S, Wang S-T, Lai C-T, Lin L-J, Chou P","year":"2007","unstructured":"44. Wang C-S, Wang S-T, Lai C-T, Lin L-J, Chou P, Impact of influenza vaccination on major cause-specific mortality, Vaccine, 2007;251196-203","journal-title":"Vaccine"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1136\/thx.2008.106286","article-title":"Influenza but not pneumococcal vaccinatio nprotects against all-cause mor-tality in patients with COPD","volume":"64","author":"Schembri S, Morant S, Winter JH, MacDonald TM","year":"2009","unstructured":"45. Schembri S, Morant S, Winter JH, MacDonald TM, Influenza but not pneumococcal vaccinatio nprotects against all-cause mor-tality in patients with COPD, Thorax, 2009;64567-72","journal-title":"Thorax"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.09.048","article-title":"The disease burden of influenza beyond respiratory illness","author":"Macias AE, McElhaney JE, Chaves SS, Nealon J, Nunes MC, Samson SI","year":"2021","unstructured":"46. Macias AE, McElhaney JE, Chaves SS, Nealon J, Nunes MC, Samson SI, The disease burden of influenza beyond respiratory illness, Vaccine, 2021;","journal-title":"Vaccine"},{"issue":"2","key":"ref47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1056\/NEJMra1808137","article-title":"Acute Infection and Myocardial Infarction","volume":"380","author":"Musher DM, Abers MS, Corrales-Medina VF","year":"2019","unstructured":"47. Musher DM, Abers MS, Corrales-Medina VF, Acute Infection and Myocardial Infarction, N Engl J Med, 2019;380(2):171-176","journal-title":"N Engl J Med"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1136\/heartjnl-2015-307691","article-title":"Acute myocardial infarction and influenza: a meta-analysis of case-control studies","volume":"101","author":"Barnes M, Heywood AE, Mahimbo A, Rahman B, Newall AT, Macintyre CR","year":"2015","unstructured":"48. Barnes M, Heywood AE, Mahimbo A, Rahman B, Newall AT, Macintyre CR, Acute myocardial infarction and influenza: a meta-analysis of case-control studies, Heart, 2015;1011738-47","journal-title":"Heart"},{"issue":"10","key":"ref49","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.amjmed.2019.05.002","article-title":"Outcomes of Acute Myocardial Infarction in Patients with Influenza and Other Viral Respiratory Infections","volume":"132","author":"Vejpongsa P, Kitkungvan D, Madjid M, Charitakis K, Anderson HV, Arain S","year":"2019","unstructured":"49. Vejpongsa P, Kitkungvan D, Madjid M, Charitakis K, Anderson HV, Arain S, Outcomes of Acute Myocardial Infarction in Patients with Influenza and Other Viral Respiratory Infections, Am J Med, 2019;132(10):1173-1181","journal-title":"Am J Med"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"A6","DOI":"10.1016\/j.vaccine.2020.09.048","article-title":"The disease burden of influenza beyond respiratory illness","volume":"39","author":"Macias AE, McElhaney JE, Chaves SS, Nealon J, Nunes MC, Samson SI","year":"2021","unstructured":"50. Macias AE, McElhaney JE, Chaves SS, Nealon J, Nunes MC, Samson SI, The disease burden of influenza beyond respiratory illness, Vaccine, 2021;39(Suppl 1):A6-A14","journal-title":"Vaccine"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"e019671","DOI":"10.1161\/JAHA.120.019671","article-title":"Determinants of influenza vaccine uptake in patients with cadiovascular disease and strategies for improvement","volume":"10","author":"Bhugra P, Grandhi GR, Mszar R, Satish P, Singh R, Blaha M","year":"2021","unstructured":"51. Bhugra P, Grandhi GR, Mszar R, Satish P, Singh R, Blaha M, Determinants of influenza vaccine uptake in patients with cadiovascular disease and strategies for improvement, J Am Heart Assoc, 2021;10e019671","journal-title":"J Am Heart Assoc"},{"issue":"21","key":"ref52","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1136\/heartjnl-2015-307691","article-title":"Acute myocardial infarction and influenza: a meta-analysis of case-control studies","volume":"101","author":"Barnes M, Heywood AE, Mahimbo A, Rahman B, Newall AT, Macintyre CR","year":"2015","unstructured":"52. Barnes M, Heywood AE, Mahimbo A, Rahman B, Newall AT, Macintyre CR, Acute myocardial infarction and influenza: a meta-analysis of case-control studies, Heart, 2015;101(21):1738-47","journal-title":"Heart"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1136\/heartjnl-2016-309983","article-title":"Influenza vaccine as a coronary intervention for prevention of myocardial infarction","volume":"102","author":"MacIntyre CR, Mahimbo A, Moa AM, Barnes M","year":"2016","unstructured":"53. MacIntyre CR, Mahimbo A, Moa AM, Barnes M, Influenza vaccine as a coronary intervention for prevention of myocardial infarction, Heart, 2016;1021953-6","journal-title":"Heart"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1161\/CIRCULATIONAHA.109.891523","article-title":"Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes","volume":"121","author":"Chow CK, Jolly S, Rao-Melacini P, Fox KAA, Anand SS, Yusuf S","year":"2010","unstructured":"54. Chow CK, Jolly S, Rao-Melacini P, Fox KAA, Anand SS, Yusuf S, Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes, Circulation, 2010;121750-8","journal-title":"Circulation"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"20656","DOI":"10.1038\/s41598-020-77679-7","article-title":"Protective effect of influenza vaccination on cardiovascular diseases: a systematic review and meta-analysis","volume":"10","author":"Zangiabadian M, Nejadghaderi SA, Mirsaeidi M, Hajikhani B, Goudarzi M, Goudarzi H","year":"2020","unstructured":"55. Zangiabadian M, Nejadghaderi SA, Mirsaeidi M, Hajikhani B, Goudarzi M, Goudarzi H, Protective effect of influenza vaccination on cardiovascular diseases: a systematic review and meta-analysis, SciRep, 2020;1020656","journal-title":"SciRep"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"e228873","DOI":"10.1001\/jamanetworkopen.2022.8873","article-title":"Association of influenza vaccination with cardiovascular risk","volume":"5","author":"Behrouzi B, Bhatt DL, Cannon CP, Vardeny O, Lee DS, Solomon SD","year":"2022","unstructured":"56. Behrouzi B, Bhatt DL, Cannon CP, Vardeny O, Lee DS, Solomon SD, Association of influenza vaccination with cardiovascular risk, JAMA Netw Open, 2022;5e228873","journal-title":"JAMA Netw Open"},{"key":"ref57","article-title":"Influenza vaccination: proven and effective cardiovascular disease prevention","author":"Coleman King S, Parker Fiebelkorn AS, Sperling L","year":"2020","unstructured":"57. Coleman King S, Parker Fiebelkorn AS, Sperling L, Influenza vaccination: proven and effective cardiovascular disease prevention, American College of Cardiology:2020;Available from: https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2020\/11\/02\/14\/42\/influenza-vaccination-proven-and-effective-cvd-prevention"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"3599726","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M","year":"2021","unstructured":"58. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, Eur Heart J, 2021;423599726","journal-title":"Eur Heart J"},{"issue":"3","key":"ref59","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C","year":"2020","unstructured":"59. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes, Eur Heart J, 2020;41(3):407-477","journal-title":"Eur Heart J"},{"key":"ref60","article-title":"IDF Diabetes Atlas: 10th ed","author":"International Diabetes Federation","year":"2021","unstructured":"60. International Diabetes Federation, IDF Diabetes Atlas: 10th ed, 2021;Available from: https:\/\/diabetesatlas.org"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"5095","DOI":"10.1016\/j.vaccine.2017.07.095","article-title":"Benefits of flu vaccination for persons with diabetes mellitus: ar eview","volume":"35","author":"Goeijenbier M, van Sloten TT, Slobbe L, Mathieu C, van Genderen P, Beyer WEP","year":"2017","unstructured":"61. Goeijenbier M, van Sloten TT, Slobbe L, Mathieu C, van Genderen P, Beyer WEP, Benefits of flu vaccination for persons with diabetes mellitus: ar eview, Vaccine, 2017;355095-101","journal-title":"Vaccine"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.2337\/dc09-2215","article-title":"Diabetes and the severity of pandemic influenza A(H1N1) infection","volume":"33","author":"Allard R, Leclerc P, Tremblay C, Tannenbaum T-N","year":"2010","unstructured":"62. Allard R, Leclerc P, Tremblay C, Tannenbaum T-N, Diabetes and the severity of pandemic influenza A(H1N1) infection, Diabetes Care, 2010;331491-3","journal-title":"Diabetes Care"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1177\/1932296819883340","article-title":"Quantifying the impact of influenza among persons with type 2 diabetes mellitus: a new approach to determine medical and physical activity impact","volume":"15","author":"Samson SI, Konty K, Lee W-N, Quise lT, Foschini L, Kerr D","year":"2021","unstructured":"63. Samson SI, Konty K, Lee W-N, Quise lT, Foschini L, Kerr D, Quantifying the impact of influenza among persons with type 2 diabetes mellitus: a new approach to determine medical and physical activity impact, J Diabetes Sci Technol, 2021;1544-52","journal-title":"J Diabetes Sci Technol"},{"key":"ref64","article-title":"People with diabetes and the flu","author":"Centers for Disease Control and Prevention","year":"2023","unstructured":"64. Centers for Disease Control and Prevention, People with diabetes and the flu, 2023;Available from: https:\/\/www.cdc.gov\/flu\/highrisk\/diabetes.htm"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.2337\/dc22-S004","article-title":"Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes\u20142022","volume":"45","author":"American Diabetes Association","year":"2022","unstructured":"65. American Diabetes Association, Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes\u20142022, Diabetes Care, 2022;45S46-59","journal-title":"Diabetes Care"},{"issue":"1","key":"ref66","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.maturitas.2015.05.004","article-title":"Immunosenescence: Implications for response to infection and vaccination in older people","volume":"82","author":"Pera A, Campos C, L\u00f3pez N, Hassouneh F, Alonso C, Tarazona R, Solana R","year":"2015","unstructured":"66. Pera A, Campos C, L\u00f3pez N, Hassouneh F, Alonso C, Tarazona R, Solana R, Immunosenescence: Implications for response to infection and vaccination in older people, Maturitas, 2015;82(1):50-5","journal-title":"Maturitas"},{"key":"ref67","article-title":"Romania in Figures 2023. Bucharest: National Institute of Statistics; 2023","author":"National Institute of Statistics, Romania","unstructured":"67. National Institute of Statistics, Romania, Romania in Figures 2023. Bucharest: National Institute of Statistics; 2023, Available from: https:\/\/insse.ro\/cms\/sites\/default\/files\/field\/publicatii\/romania_in_figures_2023.pdf"},{"issue":"6","key":"ref68","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.4110\/in.2019.19.e37","article-title":"Aging and the Immune System: the Impact of Immunosenescence on Viral Infection, Immunity and Vaccine Immunogenicity","volume":"19","author":"Oh S-J, Lee LK, Shin S","year":"2019","unstructured":"68. Oh S-J, Lee LK, Shin S, Aging and the Immune System: the Impact of Immunosenescence on Viral Infection, Immunity and Vaccine Immunogenicity, Immune Netw, 2019;19(6):e37","journal-title":"Immune Netw"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ","year":"2003","unstructured":"69. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Mortality associated with influenza and respiratory syncytial virus in the United States, JAMA, 2003;289179","journal-title":"JAMA"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/cid\/cis211","article-title":"Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008","volume":"54","author":"Zhou H, Thompson WW, Viboud CG, Ringholz CM, Cheng P-Y, Steiner C","year":"2012","unstructured":"70. Zhou H, Thompson WW, Viboud CG, Ringholz CM, Cheng P-Y, Steiner C, Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008, Clin Infect Dis, 2012;541427-36","journal-title":"Clin Infect Dis"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ijid.2020.02.040","article-title":"Who and when to vaccinate against influenza","volume":"93","author":"Buchy P, Badur S","year":"2020","unstructured":"71. Buchy P, Badur S, Who and when to vaccinate against influenza, Int J Infect Dis, 2020;93375-87","journal-title":"Int J Infect Dis"},{"issue":"4","key":"ref72","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.arr.2011.03.003","article-title":"Aging with multimorbidity: a systematic review of the literature","volume":"10","author":"Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A","year":"2011","unstructured":"72. Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, Aging with multimorbidity: a systematic review of the literature, Ageing Res Rev, 2011;10(4):430-9","journal-title":"Ageing Res Rev"},{"issue":"4","key":"ref73","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1183\/09031936.00059814","article-title":"Ageing and the epidemiology of multimorbidity","volume":"44","author":"Divo MJ, Martinez CH, Mannino DM","year":"2014","unstructured":"73. Divo MJ, Martinez CH, Mannino DM, Ageing and the epidemiology of multimorbidity, Eur Respir J, 2014;44(4):1055-1068","journal-title":"Eur Respir J"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2147\/CIA.S45300","article-title":"Frailty syndrome: an overview","volume":"9","author":"Chen X, Mao G, Leng SX","year":"2014","unstructured":"74. Chen X, Mao G, Leng SX, Frailty syndrome: an overview, Clin Interv Aging, 2014;9433-441","journal-title":"Clin Interv Aging"},{"issue":"8","key":"ref75","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/j.1532-5415.2012.04054.x","article-title":"Prevalence of frailty in community-dwelling older persons: a systematic review","volume":"60","author":"Collard RM, Boter H, Schoevers RA, Oude Voshaar RC","year":"2012","unstructured":"75. Collard RM, Boter H, Schoevers RA, Oude Voshaar RC, Prevalence of frailty in community-dwelling older persons: a systematic review, J Am Geriatr Soc, 2012;60(8):1487-92","journal-title":"J Am Geriatr Soc"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"101351","DOI":"10.1016\/j.arr.2021.101351","article-title":"Fostering healthy aging: The interdependency of infections, immunity and frailty","volume":"69","author":"Vetrano DL, Triolo F, Maggi S, Malley R, Jackson TA, Poscia A","year":"2021","unstructured":"76. Vetrano DL, Triolo F, Maggi S, Malley R, Jackson TA, Poscia A, Fostering healthy aging: The interdependency of infections, immunity and frailty, Ageing Res Rev, 2021;69101351","journal-title":"Ageing Res Rev"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1056\/NEJ-Moa070844","article-title":"Effectiveness of influenza vaccine in the community-dwelling elderly","volume":"357","author":"Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E","year":"2007","unstructured":"77. Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E, Effectiveness of influenza vaccine in the community-dwelling elderly, N Engl J Med, 2007;3571373-81","journal-title":"N Engl J Med"},{"issue":"8","key":"ref78","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.vaccine.2005.08.105","article-title":"Antibody response to influenza vaccination in the elderly: a quantitative review","volume":"24","author":"Goodwin K, Viboud C, Simonsen L","year":"2006","unstructured":"78. Goodwin K, Viboud C, Simonsen L, Antibody response to influenza vaccination in the elderly: a quantitative review, Vaccine, 2006;24(8):1159-69","journal-title":"Vaccine"},{"issue":"37","key":"ref79","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.1016\/j.vaccine.2009.06.03","article-title":"Influenza control in the 21st century: Optimizing protection of older adults","volume":"27","author":"Monto AS, Ansaldi F, Aspinall R, McElhaney JE, Monta\u00f1o LF, Nichol KL","year":"2009","unstructured":"79. Monto AS, Ansaldi F, Aspinall R, McElhaney JE, Monta\u00f1o LF, Nichol KL, Influenza control in the 21st century: Optimizing protection of older adults, Vaccine, 2009;27(37):5043-53","journal-title":"Vaccine"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"103998","DOI":"10.1016\/j.cellimm.2019.103998","article-title":"Aging and influenza vaccine-induced immunity","volume":"348","author":"Dugan HL, Henry C, Wilson PC","year":"2020","unstructured":"80. Dugan HL, Henry C, Wilson PC, Aging and influenza vaccine-induced immunity, Cell Immunol, 2020;348103998","journal-title":"Cell Immunol"},{"issue":"21","key":"ref81","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1016\/j.vaccine.2017.03.092","article-title":"Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis","volume":"35","author":"Wilkinson K, Wei Y, Szwajcer A, Rabbani R, Zarychanski R, Abou-Setta AM","year":"2017","unstructured":"81. Wilkinson K, Wei Y, Szwajcer A, Rabbani R, Zarychanski R, Abou-Setta AM, Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis, Vaccine, 2017;35(21):2775-2780","journal-title":"Vaccine"},{"issue":"7","key":"ref82","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1056\/NEJMoa1315727","article-title":"Efficacy of high-dose versus standard-dose influenza vaccine in older adults","volume":"371","author":"DiazGranados CA, Dunning AJ, Kimmel M, Kirby D, Treanor J, Collins A","year":"2014","unstructured":"82. DiazGranados CA, Dunning AJ, Kimmel M, Kirby D, Treanor J, Collins A, Efficacy of high-dose versus standard-dose influenza vaccine in older adults, N Engl J Med, 2014;371(7):635-45","journal-title":"N Engl J Med"},{"issue":"9","key":"ref83","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S2213-2600(17)30235-7","article-title":"Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial","volume":"5","author":"Gravenstein S, Davidson HE, Taljaard M, Ogarek J, Gozalo P, Han L","year":"2017","unstructured":"83. Gravenstein S, Davidson HE, Taljaard M, Ogarek J, Gozalo P, Han L, Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial, Lancet Respir Med, 2017;5(9):738-746","journal-title":"Lancet Respir Med"},{"issue":"3","key":"ref84","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1080\/21645515.2017.1398872","article-title":"Feasibility of a cluster-randomized influenza vaccination trial in U.S nursing homes: Lessons learned","volume":"14","author":"Gravenstein S, Davidson HE, Han LF, Ogarek JA, Dahal R, Gozalo PL","year":"2018","unstructured":"84. Gravenstein S, Davidson HE, Han LF, Ogarek JA, Dahal R, Gozalo PL, Feasibility of a cluster-randomized influenza vaccination trial in U.S nursing homes: Lessons learned, Hum Vaccin Immunother, 2018;14(3):736-743","journal-title":"Hum Vaccin Immunother"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"A24","DOI":"10.1016\/j.vaccine.2020.09.004","article-title":"Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis","volume":"39","author":"Lee JKH, Lam GKL, Shin T, Samson SI, Greenberg DP, Chit A","year":"2021","unstructured":"85. Lee JKH, Lam GKL, Shin T, Samson SI, Greenberg DP, Chit A, Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis, Vaccine, 2021;39(Suppl 1):A24-A35","journal-title":"Vaccine"},{"issue":"12","key":"ref86","doi-asserted-by":"publisher","first-page":"5475","DOI":"10.1080\/21645515.2021.1983387","article-title":"Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial","volume":"17","author":"Pepin S, Nicolas JF, Szymanski H, Leroux-Roels I, Schaum T, Bonten M","year":"2021","unstructured":"86. Pepin S, Nicolas JF, Szymanski H, Leroux-Roels I, Schaum T, Bonten M, Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial, Hum Vaccin Immunother, 2021;17(12):5475-5486","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"ref87","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1086\/599790","article-title":"Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older","volume":"200","author":"Falsey AR, Treanor JJ, Tornieporth N, Capellan J, Gorse GJ","year":"2009","unstructured":"87. Falsey AR, Treanor JJ, Tornieporth N, Capellan J, Gorse GJ, Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older, J Infect Dis, 2009;200(2):172-80","journal-title":"J Infect Dis"},{"issue":"1","key":"ref88","doi-asserted-by":"publisher","first-page":"ofx001","DOI":"10.1093\/ofid\/ofx001","article-title":"Comparison of Side Effects of the 2015-2016 High-Dose, Inactivated, Trivalent Influenza Vaccine and Standard Dose, Inactivated, Trivalent Influenza Vaccine in Adults \u226565 Years","volume":"4","author":"Kaka AS, Filice GA, Myllenbeck S, Nichol KL","year":"2017","unstructured":"88. Kaka AS, Filice GA, Myllenbeck S, Nichol KL, Comparison of Side Effects of the 2015-2016 High-Dose, Inactivated, Trivalent Influenza Vaccine and Standard Dose, Inactivated, Trivalent Influenza Vaccine in Adults \u226565 Years, Open Forum Infect Dis, 2017;4(1):ofx001","journal-title":"Open Forum Infect Dis"},{"issue":"11","key":"ref89","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1093\/cid\/cis256","article-title":"Postlicensure safety surveillance for high-dose trivalent inactivated influenza vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010","volume":"54","author":"Moro PL, Arana J, Cano M, Menschik D, Yue X, Lewis P","year":"2012","unstructured":"89. Moro PL, Arana J, Cano M, Menschik D, Yue X, Lewis P, Postlicensure safety surveillance for high-dose trivalent inactivated influenza vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010, Clin Infect Dis, 2012;54(11):1608-14","journal-title":"Clin Infect Dis"},{"issue":"37","key":"ref90","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1016\/j.vaccine.2020.07.007","article-title":"Monitoring the safety of high-dose, trivalent inactivated influenza vaccine in the vaccine adverse event reporting system (VAERS), 2011-2019","volume":"38","author":"Moro PL, Woo EJ, Marquez P, Cano M","year":"2020","unstructured":"90. Moro PL, Woo EJ, Marquez P, Cano M, Monitoring the safety of high-dose, trivalent inactivated influenza vaccine in the vaccine adverse event reporting system (VAERS), 2011-2019, Vaccine, 2020;38(37):5923-5926","journal-title":"Vaccine"},{"key":"ref91","article-title":"Seasonal influenza vaccines systematic review","author":"ECDC","unstructured":"91. ECDC, Seasonal influenza vaccines systematic review, Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/seasonal-influenza-vaccines-systematic-review-efficacy.pdf (Accessed April 2023)"},{"issue":"1","key":"ref92","doi-asserted-by":"publisher","first-page":"e13071","DOI":"10.1111\/irv.13071","article-title":"Enhanced passive safety surveillance of high-dose and standard-dose quadrivalent inactivated split-virion influenza vaccines in Germany and Finland during the influenza season 2021\/22","volume":"17","author":"Gandhi-Banga S, Wague S, Shrestha A, Syrkina O, Talanova O, Nissil\u00e4 M","year":"2023","unstructured":"92. Gandhi-Banga S, Wague S, Shrestha A, Syrkina O, Talanova O, Nissil\u00e4 M, Enhanced passive safety surveillance of high-dose and standard-dose quadrivalent inactivated split-virion influenza vaccines in Germany and Finland during the influenza season 2021\/22, Influenza Other Respir Viruses, 2023;17(1):e13071","journal-title":"Influenza Other Respir Viruses"},{"key":"ref93","article-title":"Second-year experience of implementing STIKO-recommendation for high dose quadrivalent influenza vaccine for adults 60 years and older in Germany","author":"Brysch P, Machado M, Banga S, Kauschat D, Levant MC","year":"2023","unstructured":"93. Brysch P, Machado M, Banga S, Kauschat D, Levant MC, Second-year experience of implementing STIKO-recommendation for high dose quadrivalent influenza vaccine for adults 60 years and older in Germany, Abstract Book of the ESWI Conference, 2023;Valencia, Spain","journal-title":"Abstract Book of the ESWI Conference"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12916-016-0627-1","article-title":"The importance of collecting structured clinical information on multiple sclerosis","volume":"14","author":"Ziemssen T, Hillert J, Butzkueven H","year":"2016","unstructured":"94. Ziemssen T, Hillert J, Butzkueven H, The importance of collecting structured clinical information on multiple sclerosis, BMC Med, 2016;1481","journal-title":"BMC Med"},{"key":"ref95","article-title":"Vision for use of real-world evidence in EU medicines regulation","author":"European Medicines Agency","year":"2023","unstructured":"95. European Medicines Agency, Vision for use of real-world evidence in EU medicines regulation, 2023;Available from: https:\/\/www.ema.europa.eu\/en\/news\/vision-use-real-world-evidence-eu-medicines-regulation#share"},{"issue":"1","key":"ref96","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s40814-022-01044-w","article-title":"Feasibility of randomizing Danish citizens aged 65-79 years to high-dose quadrivalent influenza vaccine vs standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial","volume":"8","author":"Johansen ND, Modin D, Nealon J, Samson S, Salamand C, Larsen CS","year":"2022","unstructured":"96. Johansen ND, Modin D, Nealon J, Samson S, Salamand C, Larsen CS, Feasibility of randomizing Danish citizens aged 65-79 years to high-dose quadrivalent influenza vaccine vs standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial, Pilot Feasibility Stud, 2022;8(1):87","journal-title":"Pilot Feasibility Stud"},{"key":"ref97","author":"Resolution and scientific justification of the Standing Vaccination Commission (STIKO) for updating the influenza vaccination recommendation for people aged 60 years","year":"2021","unstructured":"97. Resolution and scientific justification of the Standing Vaccination Commission (STIKO) for updating the influenza vaccination recommendation for people aged 60 years, Epidemiologisches Bulletin, 2021;(online in advance)","journal-title":"Epidemiologisches Bulletin"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"100327","DOI":"10.1016\/j.jvacx.2023.100327","article-title":"High-dose influenza vaccine in older adults by age and seasonal characteristics: Systematic review and meta-analysis update","volume":"14","author":"Lee JKH, Lam GKL, Yin JK, Loiacono MM, Samson SI","year":"2023","unstructured":"98. Lee JKH, Lam GKL, Yin JK, Loiacono MM, Samson SI, High-dose influenza vaccine in older adults by age and seasonal characteristics: Systematic review and meta-analysis update, Vaccine X, 2023;14100327","journal-title":"Vaccine X"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1101\/2023.06.15.23291345","article-title":"The relative effectiveness of a high-dose quadrivalent influenza vaccine vs standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 2021-22 influenza season","author":"Bricout H, Levant MC, Assi N, Cr\u00e9pey P, Descamps A, Mari K","year":"2023","unstructured":"99. Bricout H, Levant MC, Assi N, Cr\u00e9pey P, Descamps A, Mari K, The relative effectiveness of a high-dose quadrivalent influenza vaccine vs standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 2021-22 influenza season, medRxiv [Preprint], 2023;Available from: https:\/\/www.medrxiv.org\/content\/10.1101\/2023.06.15.23291345v1","journal-title":"medRxiv [Preprint]"},{"key":"ref100","article-title":"Seasonal influenza vaccination and antiviral use in EU\/EEA member states","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2018","unstructured":"100. European Centre for Disease Prevention and Control (ECDC), Seasonal influenza vaccination and antiviral use in EU\/EEA member states, 2018;Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/seasonal-influenza-antiviral-use-2018.pdf"},{"key":"ref101","article-title":"Analiza evolu\u021biei gripei, a infec\u021biilor respiratorii acute (ARI) \u0219i a infec\u021biilor respiratorii acute severe (SARI) \u00een sezonul","author":"Institutul Na\u021bional de S\u0103n\u0103tate Public\u0103","year":"2023-2024","unstructured":"101. Institutul Na\u021bional de S\u0103n\u0103tate Public\u0103, Analiza evolu\u021biei gripei, a infec\u021biilor respiratorii acute (ARI) \u0219i a infec\u021biilor respiratorii acute severe (SARI) \u00een sezonul, 2023-2024;"},{"issue":"1","key":"ref102","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1080\/13696998.2023.2194193","article-title":"Cost-effectiveness of influenza vaccination with a high dose quadrivalent vaccine of the elderly population in Belgium, Finland, and Portugal","volume":"26","author":"Alvarez FP, Chevalier P, Borms M, Bricout H, Marques C, Soininen A","year":"2023","unstructured":"102. Alvarez FP, Chevalier P, Borms M, Bricout H, Marques C, Soininen A, Cost-effectiveness of influenza vaccination with a high dose quadrivalent vaccine of the elderly population in Belgium, Finland, and Portugal, J Med Econ, 2023;26(1):710-719","journal-title":"J Med Econ"},{"key":"ref103","first-page":"S15","article-title":"Influenza in older patients: a call to action and recent updates for vaccinations","volume":"24","author":"Wilhelm M","year":"2018","unstructured":"103. Wilhelm M, Influenza in older patients: a call to action and recent updates for vaccinations, Am J Manag Care, 2018;24(2 Suppl):S15-S24","journal-title":"Am J Manag Care"},{"key":"ref104","article-title":"Systematic review of the efficacy, effectiveness, and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals aged 18 years and over","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2020","unstructured":"104. European Centre for Disease Prevention and Control (ECDC), Systematic review of the efficacy, effectiveness, and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals aged 18 years and over, 2020;Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/seasonal-influenza-vaccines-systematic-review-efficacy.pdf"},{"issue":"1","key":"ref105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7101a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2022\u201323 influenza season","volume":"71","author":"Centers for Disease Control and Prevention (CDC)","year":"2022","unstructured":"105. Centers for Disease Control and Prevention (CDC), Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2022\u201323 influenza season, MMWR Recomm Rep, 2022;71(1):1-28Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/71\/rr\/rr7101a1.htm","journal-title":"MMWR Recomm Rep"},{"key":"ref106","first-page":"1","article-title":"Influenza season 2021\/22 in Germany: a summary of surveillance findings","volume":"04","author":"Robert Koch Institute","year":"2022","unstructured":"106. Robert Koch Institute, Influenza season 2021\/22 in Germany: a summary of surveillance findings, Epidemiologisches Bulletin, 2022;041-16Available from: https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2022\/Ausgaben\/04_22.pdf?__blob=publicationFile","journal-title":"Epidemiologisches Bulletin"},{"key":"ref107","article-title":"Vaccin anti-grippal Efluelda: les recommandations de la SFGG","author":"Soci\u00e9t\u00e9 Fran\u00e7aise de G\u00e9riatrie et G\u00e9rontologie (SFGG)","year":"2022","unstructured":"107. Soci\u00e9t\u00e9 Fran\u00e7aise de G\u00e9riatrie et G\u00e9rontologie (SFGG), Vaccin anti-grippal Efluelda: les recommandations de la SFGG, 2022;Available from: https:\/\/sfgg.org\/actualites\/vaccin-anti-grippal-efluelda-les-recommandations-de-la-sfgg\/"},{"issue":"5","key":"ref108","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.pulmoe.2023.11.003","article-title":"Influenza vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Society of Cardiology, the Portuguese Society of Diabetology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Geriatrics and Gerontology, and the Study Group of Geriatrics of the Portuguese Society of Internal Medicine","volume":"30","author":"Morais A","year":"2024","unstructured":"108. Morais A, Influenza vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Society of Cardiology, the Portuguese Society of Diabetology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Geriatrics and Gerontology, and the Study Group of Geriatrics of the Portuguese Society of Internal Medicine, Pulmonology, 2024;30(5):422-436","journal-title":"Pulmonology"},{"issue":"1","key":"ref109","doi-asserted-by":"publisher","first-page":"116","DOI":"10.5114\/fmpcr.2024.134715","article-title":"Towards better protection of older people against influenza and its complications","volume":"26","author":"Nitsch-Osuch A, Jankowski P, Kokoszka-Paszkot J, Kuchar E, Mastalerz-Migas A, Mitkowski P","year":"2024","unstructured":"109. Nitsch-Osuch A, Jankowski P, Kokoszka-Paszkot J, Kuchar E, Mastalerz-Migas A, Mitkowski P, Towards better protection of older people against influenza and its complications, Polish recommendations for HD influenza vaccine. Family Medicine & Primary Care Review, 2024;26(1):116-122","journal-title":"Polish recommendations for HD influenza vaccine. Family Medicine & Primary Care Review"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/all-issues\/2024\/issue-7-2024\/point-of-view-issue-7-2024\/protecting-the-elderly-from-influenza-in-the-context-of-immune-system-senescence-elderly-aged-65-and-over-are-vulnerable-to-influenza-and-its-associated-complications\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T11:12:18Z","timestamp":1730200338000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/all-issues\/2024\/issue-7-2024\/point-of-view-issue-7-2024\/protecting-the-elderly-from-influenza-in-the-context-of-immune-system-senescence-elderly-aged-65-and-over-are-vulnerable-to-influenza-and-its-associated-complications\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":109,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["JMedLife-17-746"],"URL":"https:\/\/doi.org\/10.25122\/jml-2024-0274","relation":{},"ISSN":["1844-3117"],"issn-type":[{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}